Ortiz-Gonzales X: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=Ortiz-Gonzales | |lastname=Ortiz-Gonzales | ||
|firstname=Xilma | |firstname=Xilma | ||
|institution=Center for Mitochondrial and Epigenomic Medicine (CMEM) | |institution=Center for Mitochondrial and Epigenomic Medicine (CMEM) | ||
| Line 17: | Line 17: | ||
|field of research=Basic | |field of research=Basic | ||
}} | }} | ||
== | == Participated at == | ||
* [[MiPNet19.06 | ::::* [[MiPNet19.06 IOC91 |IOC91 Philadelphia US]] | ||
Latest revision as of 17:05, 13 February 2018
| Name | Ortiz-Gonzales Xilma, |
|---|---|
| Institution | Center for Mitochondrial and Epigenomic Medicine (CMEM)
The Children's Hospital of Philadelphia - Research Institute Colket Translational Research Building |
| Address | 3501 Civic Center Blvd, 19104 |
| City | Philadelphia |
| State/Province | Pennsylvania (PA) |
| Country | USA |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | US PA Philadelphia Wallace DC |
Labels:
Field of research: Basic
Publications
| Published | Reference | |
|---|---|---|
| Gustafson 2019 PLoS One | 2019 | Gustafson MA, McCormick EM, Perera L, Longley MJ, Bai R, Kong J, Dulik M, Shen L, Goldstein AC, McCormack SE, Laskin BL, Leroy BP, Ortiz-Gonzalez XR, Ellington MG, Copeland WC, Falk MJ (2019) Mitochondrial single-stranded DNA binding protein novel de novo SSBP1 mutation in a child with single large-scale mtDNA deletion (SLSMD) clinically manifesting as Pearson, Kearns-Sayre, and Leigh syndromes. PLoS One 14:e0221829. |
